• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双萘甲酰亚胺基丙基衍生物作为利什曼原虫 SIR2 相关蛋白 1 的抑制剂。

Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.

机构信息

IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Rua do Campo Alegre 823, 4150-180 Porto, Portugal.

出版信息

ChemMedChem. 2010 Jan;5(1):140-7. doi: 10.1002/cmdc.200900367.

DOI:10.1002/cmdc.200900367
PMID:19937668
Abstract

The NAD(+)-dependent deacetylases, namely sirtuins, are involved in the regulation of a variety of biological processes such as gene silencing, DNA repair, longevity, metabolism, apoptosis, and development. An enzyme from the parasite Leishmania infantum that belongs to this family, LiSIR2RP1, is a NAD(+)-dependent tubulin deacetylase and an ADP-ribosyltransferase. This enzyme's involvement in L. infantum virulence and survival underscores its potential as a drug target. Our search for selective inhibitors of LiSIR2RP1 has led, for the first time, to the identification of the antiparasitic and anticancer bisnaphthalimidopropyl (BNIP) alkyl di- and triamines (IC(50) values in the single-digit micromolar range for the most potent compounds). Structure-activity studies were conducted with 12 BNIP derivatives that differ in the length of the central alkyl chain, which links the two naphthalimidopropyl moieties. The most active and selective compound is the BNIP diaminononane (BNIPDanon), with IC(50) values of 5.7 and 97.4 microM against the parasite and human forms (SIRT1) of the enzyme, respectively. Furthermore, this compound is an NAD(+)-competitive inhibitor that interacts differently with the parasite and human enzymes, as determined by docking analysis, which might explain its selectivity toward the parasitic enzyme.

摘要

NAD(+)依赖性脱乙酰酶,即沉默调节蛋白,参与调节多种生物学过程,如基因沉默、DNA 修复、长寿、代谢、细胞凋亡和发育。属于该家族的寄生虫利什曼原虫中的一种酶,LiSIR2RP1,是一种 NAD(+)依赖性微管脱乙酰酶和 ADP-核糖基转移酶。这种酶参与利什曼原虫的毒力和存活,突出了它作为药物靶点的潜力。我们首次寻找 LiSIR2RP1 的选择性抑制剂,导致发现了具有抗寄生虫和抗癌活性的双萘酰亚胺丙基(BNIP)二烷基和三烷基胺(最有效的化合物的 IC(50)值在个位数微摩尔范围内)。用 12 种 BNIP 衍生物进行了结构活性研究,这些衍生物在连接两个萘酰亚胺丙基部分的中央烷基链的长度上有所不同。最活跃和选择性的化合物是 BNIP 二氨基壬烷(BNIPDanon),对寄生虫和人类形式(SIRT1)的酶的 IC(50)值分别为 5.7 和 97.4 microM。此外,该化合物是一种 NAD(+)竞争性抑制剂,与寄生虫和人类酶的相互作用方式不同,这是通过对接分析确定的,这可能解释了它对寄生酶的选择性。

相似文献

1
Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.双萘甲酰亚胺基丙基衍生物作为利什曼原虫 SIR2 相关蛋白 1 的抑制剂。
ChemMedChem. 2010 Jan;5(1):140-7. doi: 10.1002/cmdc.200900367.
2
The Leishmania infantum cytosolic SIR2-related protein 1 (LiSIR2RP1) is an NAD+ -dependent deacetylase and ADP-ribosyltransferase.婴儿利什曼原虫胞质SIR2相关蛋白1(LiSIR2RP1)是一种依赖烟酰胺腺嘌呤二核苷酸(NAD+)的去乙酰化酶和ADP核糖基转移酶。
Biochem J. 2008 Nov 1;415(3):377-86. doi: 10.1042/BJ20080666.
3
Anti-leishmanial activity of the bisnaphthalimidopropyl derivatives.双萘二甲酰亚胺丙基衍生物的抗利什曼原虫活性。
Parasitol Int. 2012 Jun;61(2):360-3. doi: 10.1016/j.parint.2011.11.005. Epub 2011 Dec 6.
4
Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins).作为NAD+依赖的组蛋白去乙酰化酶(沉默调节蛋白)抑制剂的苏拉明类似物的构效关系研究
ChemMedChem. 2007 Oct;2(10):1419-31. doi: 10.1002/cmdc.200700003.
5
Stage-specific antileishmanial activity of an inhibitor of SIR2 histone deacetylase.SIR2组蛋白去乙酰化酶抑制剂的阶段特异性抗利什曼原虫活性
Acta Trop. 2005 May;94(2):107-15. doi: 10.1016/j.actatropica.2005.03.004. Epub 2005 Apr 26.
6
Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin.苏拉明对人NAD⁺依赖性脱乙酰酶SIRT5的抑制作用的结构基础
Structure. 2007 Mar;15(3):377-89. doi: 10.1016/j.str.2007.02.002.
7
The synthesis and the in vitro cytotoxicity studies of bisnaphthalimidopropyl polyamine derivatives against colon cancer cells and parasite Leishmania infantum.双萘二甲酰亚胺丙基多胺衍生物对结肠癌细胞和婴儿利什曼原虫的合成及体外细胞毒性研究
Bioorg Med Chem. 2007 Jan 1;15(1):541-5. doi: 10.1016/j.bmc.2006.09.031. Epub 2006 Sep 28.
8
Novel Synthetic Approaches for Bisnaphthalimidopropyl (BNIP) Derivatives as Potential Anti-Parasitic Agents for the Treatment of Leishmaniasis.新型双萘并异吲哚基丙基(BNIP)衍生物的合成方法研究进展及其作为抗利什曼原虫病治疗药物的潜在应用。
Molecules. 2019 Dec 16;24(24):4607. doi: 10.3390/molecules24244607.
9
Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicity.一种具有选择性肿瘤细胞毒性的小分子SIRT2抑制剂的鉴定。
Biochem Biophys Res Commun. 2009 Sep 4;386(4):729-33. doi: 10.1016/j.bbrc.2009.06.113. Epub 2009 Jun 25.
10
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition.作为NAD⁺依赖性组蛋白脱乙酰酶抑制剂的腺苷模拟物,从激酶抑制到沉默调节蛋白抑制
J Med Chem. 2006 Dec 14;49(25):7307-16. doi: 10.1021/jm060118b.

引用本文的文献

1
Fragment Screening Reveals Novel Scaffolds against Sirtuin-2-Related Protein 1 from .片段筛选揭示了针对来自……的与沉默调节蛋白2相关蛋白1的新型骨架。
ACS Omega. 2024 Dec 27;10(4):3808-3819. doi: 10.1021/acsomega.4c09231. eCollection 2025 Feb 4.
2
Roles of ADP-Ribosylation during Infection Establishment by Parasites.寄生虫在感染建立过程中ADP核糖基化的作用。
Pathogens. 2023 May 12;12(5):708. doi: 10.3390/pathogens12050708.
3
Sirtuin 2 as a Relevant Druggable Target: New Inhibitors Developed by Computer-Aided Drug Design.沉默调节蛋白2作为一个相关的可成药靶点:通过计算机辅助药物设计开发的新型抑制剂
Pharmaceuticals (Basel). 2023 Mar 10;16(3):428. doi: 10.3390/ph16030428.
4
Novel Synthetic Approaches for Bisnaphthalimidopropyl (BNIP) Derivatives as Potential Anti-Parasitic Agents for the Treatment of Leishmaniasis.新型双萘并异吲哚基丙基(BNIP)衍生物的合成方法研究进展及其作为抗利什曼原虫病治疗药物的潜在应用。
Molecules. 2019 Dec 16;24(24):4607. doi: 10.3390/molecules24244607.
5
Novel lead compounds in pre-clinical development against African sleeping sickness.处于抗非洲昏睡病临床前开发阶段的新型先导化合物。
Medchemcomm. 2017 Jul 31;8(10):1872-1890. doi: 10.1039/c7md00280g. eCollection 2017 Oct 1.
6
Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.抑制克氏锥虫 Sir2 相关蛋白 1 作为治疗恰加斯病的潜在药物。
PLoS Negl Trop Dis. 2018 Jan 22;12(1):e0006180. doi: 10.1371/journal.pntd.0006180. eCollection 2018 Jan.
7
Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.新型杂芳基硒氰酸盐和二硒化物作为强效抗利什曼原虫剂
Antimicrob Agents Chemother. 2016 May 23;60(6):3802-12. doi: 10.1128/AAC.02529-15. Print 2016 Jun.
8
Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products.基于配体的虚拟筛选与归纳学习用于鉴定天然产物中的SIRT1抑制剂
Sci Rep. 2016 Jan 25;6:19312. doi: 10.1038/srep19312.
9
Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma brucei.双萘二甲酰亚胺丙基衍生物对布氏锥虫的活性。
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2532-6. doi: 10.1128/AAC.02490-15. Print 2016 Apr.
10
Identifying vaccine targets for anti-leishmanial vaccine development.鉴定抗利什曼原虫疫苗开发的疫苗靶点。
Expert Rev Vaccines. 2014 Apr;13(4):489-505. doi: 10.1586/14760584.2014.894467.